RISING PHARMA HOLDINGS INC — Lansoprazole Importer Profile
Pharmaceutical Importer · #9 buyer for Lansoprazole · $759.2K import value · 25 shipments · UNITED STATES · DGFT Verified
RISING PHARMA HOLDINGS INC is the #9 importer of Lansoprazole from India with $759.2K in import value and 25 verified shipments. RISING PHARMA HOLDINGS INC holds a 0.3% market share in Lansoprazole imports based in UNITED STATES. The company sources from 2 verified suppliers across 17 formulations shipped to 2 countries. Overall, RISING PHARMA HOLDINGS INC imports 18 pharmaceutical products worth $87.0M across 11 therapeutic categories.
RISING PHARMA HOLDINGS INC — Lansoprazole Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Lansoprazole to RISING PHARMA HOLDINGS INC?
Verified from 25 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| NATCO PHARMA LIMITED | $559.2K | 21 | 73.7% |
| AUROBINDO PHARMA LIMITED | $200.0K | 4 | 26.3% |
RISING PHARMA HOLDINGS INC sources Lansoprazole from 2 verified Indian suppliers based on 25 customs records. The primary supplier is NATCO PHARMA LIMITED accounting for 73.7% of imports.
How Does RISING PHARMA HOLDINGS INC Compare to Nearest Lansoprazole Importers?
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | ASCEND LABORATORIES,LLC | UNITED STATES | $1.1M | 22 | $50.0K |
| 12 | MYLAN PHARMACEUTICALS INC | UNITED STATES | $1.1M | 22 | $50.0K |
| 9 | RISING PHARMA HOLDINGS INC ★ | UNITED STATES | $750.0K | 15 | $50.0K |
| 2 | HEKO PHARMACY LTD | TANZANIA | $700.0K | 14 | $50.0K |
| 10 | SANDOZ CANADA INC | CANADA | $650.0K | 13 | $50.0K |
RISING PHARMA HOLDINGS INC ranks #9 among 687 Lansoprazole importers from India. Average shipment value of $50.0K compared to the market average of $28.3K. The closest competitors by value are ASCEND LABORATORIES,LLC and MYLAN PHARMACEUTICALS INC.
Where Does RISING PHARMA HOLDINGS INC Import Lansoprazole To?
Destination countries from 25 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $659.2K | 23 | 86.8% |
| UNITED STATES OF AMERICA | $100.0K | 2 | 13.2% |
RISING PHARMA HOLDINGS INC imports Lansoprazole to 2 countries. The primary destination is UNITED STATES receiving 86.8% of shipments worth $659.2K.
What Lansoprazole Formulations Does RISING PHARMA HOLDINGS INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| LANSOPRAZOLE DELAYED-RELEASE CAPSULES, A | $100.0K | 2 |
| LANSOPRAZOLE DR 30MG CAPSULES 90'S 2070 | $100.0K | 2 |
| LANSOPRAZOLE DR 30MG CAPSULES 90'S | $50.0K | 1 |
| LANSOPRAZOLE DR 15MG CAPSULES 42'S | $50.0K | 1 |
| LANSOPRAZOLE DELAYED-RELEASE CAPSULES USP 30MG AMOXICILLIN CAPSULES USP 500MG CLARITHROMYCIN TABLETS USP 500MG (4032X1 | $50.0K | 1 |
| LANSOPRAZOLE DELAYED-RELEASE CAPSULES AMOXICILLIN CAPSULES CLARITHROMYCIN TABLETS ( 30 500 500) (16344X112 S) | $50.0K | 1 |
| LANSOPRAZOLE DR 30MG CAPSULES 90'S (2792 | $50.0K | 1 |
| LANSOPRAZOLE DR 15MG CAPSULES 42'S (1521 | $50.0K | 1 |
| LANSOPRAZOLE DR 30MG CAPSULES 90'S 14796 X 90'S OTHER REF. NO. 123179 RODTEP ENTRY NO. 10100 | $48.9K | 1 |
| LANSOPRAZOLE DR 30MG CAPSULES 90'S (14904 X 90'S) (OTHER REF. NO. 123251) (RODTEP ENTRY NO. 10100)NOS | $48.5K | 3 |
RISING PHARMA HOLDINGS INC imports 17 distinct Lansoprazole formulations from India. The top formulation is LANSOPRAZOLE DELAYED-RELEASE CAPSULES, A with 2 shipments worth $100.0K.
Regulatory Requirements: Importing Lansoprazole into United States
What RISING PHARMA HOLDINGS INC and other importers must comply with to import Lansoprazole from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Lansoprazole
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Lansoprazole from India and How Much Does RISING PHARMA HOLDINGS INC Import?
India exported $19.5M worth of Lansoprazole through 4,867 shipments from 316 suppliers to 105 countries, serving 687 buyers globally. RISING PHARMA HOLDINGS INC imports $759.2K of this total, accounting for 0.3% of India's Lansoprazole exports with 25 shipments from UNITED STATES. This is verified from 25 customs shipment records covering 17 distinct formulations.
What Is the Average Order Value for RISING PHARMA HOLDINGS INC's Lansoprazole Imports?
RISING PHARMA HOLDINGS INC's average Lansoprazole order value is $30.4K per consignment, based on 25 shipments totaling $759.2K. RISING PHARMA HOLDINGS INC is based in UNITED STATES and ranks #9 among all Lansoprazole importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Lansoprazole to RISING PHARMA HOLDINGS INC?
RISING PHARMA HOLDINGS INC sources Lansoprazole from 2 verified Indian suppliers: NATCO PHARMA LIMITED ($559.2K, 73.7%), AUROBINDO PHARMA LIMITED ($200.0K, 26.3%). This is based on 25 customs records.
How Does RISING PHARMA HOLDINGS INC Compare to Other Lansoprazole Importers?
RISING PHARMA HOLDINGS INC ranks #9 among 687 Lansoprazole importers from India with a 0.3% market share. The top 3 importers are MYLAN IRELAND C/O ALLOGA RDC, ($3.2M), NUEVOS ETICOS NEOETHICALS, S.A. ($2.8M), EVERSANA LIFE SCIENCE SERVICES ($1.9M). RISING PHARMA HOLDINGS INC processed 25 shipments from UNITED STATES.
What Other Gastrointestinal Products Does RISING PHARMA HOLDINGS INC Import?
RISING PHARMA HOLDINGS INC also imports these gastrointestinal products. Each links to the detailed product page.
About RISING PHARMA HOLDINGS INC
RISING PHARMA HOLDINGS INC imports 18 products worth $87.0M. Beyond Lansoprazole, top products include Gabapentin, Furosemide, Ondansetron, Pioglitazone, Escitalopram. View the complete RISING PHARMA HOLDINGS INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lansoprazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Lansoprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: RISING PHARMA HOLDINGS INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as RISING PHARMA HOLDINGS INC's capped import value divided by total capped export value for Lansoprazole across all Indian exporters.
- 5.Verified Records: This page is backed by 25 individual customs records matching RISING PHARMA HOLDINGS INC importing Lansoprazole, covering 17 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 105+ countries, 687+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Lansoprazole Import Data for RISING PHARMA HOLDINGS INC
Access order-level details, pricing data, supplier connections, and competitive analysis for RISING PHARMA HOLDINGS INC's Lansoprazole imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
RISING PHARMA HOLDINGS INC
Full Company Profile →
18 products · $87.0M total trade · 11 categories
RISING PHARMA HOLDINGS INC × Lansoprazole
Verified from customs records
Company Overview
Top Products by RISING PHARMA HOLDINGS INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for RISING PHARMA HOLDINGS INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lansoprazole. For current order-level data, contact TransData Nexus.